A comparison of four PET tracers for brain hypoxia mapping in a rodent model of stroke

Nuclear Medicine and Biology

Volumn 40, Issue 3, 2013, Pages 338-344

  Williamson, David J ^a   Ejaz, Sohail ^a   Sitnikov, Sergey ^a   Fryer, Tim D ^a   Sawiak, Stephen J ^a   Burke, Paul ^a   Baron, Jean Claude ^a,b   Aigbirhio, Franklin I ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSERM   (France)

Author keywords

18F FAZA; 18F FMISO; 64Cu ATSE; 64Cu ATSM; Hypoxia; Positron emission tomography; Stroke

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; COPPER 64; COPPER DIACETYL BIS(N4 ETHYLTHIOSEMICARBAZONE) CU 64; COPPER DIACETYL BIS(N4 METHYLTHIOSEMICARBAZONE) CU 64; FLUORINE 18; NITROIMIDAZOLE FLUOROAZOMYCIN ARABINOSIDE F 18; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN MAPPING; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG PENETRATION; DRUG RETENTION; DRUG UPTAKE; IMAGE ANALYSIS; IMAGING SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RADIOLOGICAL PARAMETERS; RAT; TIME ACTIVITY CURVE;

ANIMALS; BRAIN; CELL HYPOXIA; DISEASE MODELS, ANIMAL; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; STROKE;

EID: 84875268576     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.11.012     Document Type: Article

References (31)

1. Astrup J., Siesjo B.K., Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981, 12:723-725.
2. Baron J.C. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis 1999, 9:193-201.
3. Muir K.W., Buchan A., von Kummer R., Rother J., Baron J.C. Imaging of acute stroke. Lancet Neurol 2006, 5:755-768.
4. Takasawa M., Moustafa R.R., Baron J.C. Applications of nitroimidazole in vivo hypoxia imaging in ischemic stroke. Stroke 2008, 39:1629-1637.
5. Rojas S., Herance J.R., Abad S., Jimenez X., Pareto D., Ruiz A., et al. Evaluation of hypoxic tissue dynamics with 18F-FMISO PET in a rat model of permanent cerebral ischemia. Mol Imaging Biol 2011, 13:558-564.
6. Takasawa M., Beech J.S., Fryer T.D., Hong Y.T., Hughes J.L., Igase K., et al. Imaging of brain hypoxia in permanent and temporary middle cerebral artery occlusion in the rat using 18F-fluoromisonidazole and positron emission tomography: a pilot study. J Cereb Blood Flow Metab 2007, 27:679-689.
7. Takasawa M., Beech J.S., Fryer T.D., Jones P.S., Ahmed T., Smith R., et al. Single-subject statistical mapping of acute brain hypoxia in the rat following middle cerebral artery occlusion: a microPET study. Exp Neurol 2011, 229:251-258.
8. Nunn A., Linder K., Strauss H.W. Nitroimidazoles and imaging hypoxia. Eur J Nucl Med 1995, 22:265-280.
9. Lee S.T., Scott A.M. Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole. Semin Nucl Med 2007, 37:451-461.
10. Chitneni S.K., Palmer G.M., Zalutsky M.R., Dewhirst M.W. Molecular imaging of hypoxia. J Nucl Med 2011, 52:165-168.
11. Piert M., Machulla H.J., Picchio M., Reischl G., Ziegler S., Kumar P., et al. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. J Nucl Med 2005, 46:106-113.
12. Postema E.J., McEwan A.J., Riauka T.A., Kumar P., Richmond D.A., Abrams D.N., et al. Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA). Eur J Nucl Med Mol Imaging 2009, 36:1565-1573.
13. Dearling J.L., Lewis J.S., Mullen G.E., Rae M.T., Zweit J., Blower P.J. Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro. Eur J Nucl Med 1998, 25:788-792.
14. Holland J.P., Lewis J.S., Dehdashti F. Assessing tumor hypoxia by positron emission tomography with Cu-ATSM. Q J Nucl Med Mol Imaging 2009, 53:193-200.
15. Fujibayashi Y., Taniuchi H., Yonekura Y., Ohtani H., Konishi J., Yokoyama A. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. J Nucl Med 1997, 38:1155-1160.
16. Lewis J.S., McCarthy D.W., McCarthy T.J., Fujibayashi Y., Welch M.J. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J Nucl Med 1999, 40:177-183.
17. McQuade P., Martin K.E., Castle T.C., Went M.J., Blower P.J., Welch M.J., et al. Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents. Nucl Med Biol 2005, 32:147-156.
18. Tamura A., Graham D.I., McCulloch J., Teasdale G.M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981, 1:53-60.
19. Burke P., Golovko O., Clark J.C., Aigbirhio F.I. An automated method for regular productions of copper-64 for pet radiopharmaceuticals. Inorg Chim Acta 2010, 363:1316-1319.
20. Oh S.J., Chi D.Y., Mosdzianowski C., Kim J.Y., Gil H.S., Kang S.H., et al. Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module. Nucl Med Biol 2005, 32:899-905.
21. Reischl G., Ehrlichmann W., Bieg C., Solbach C., Kumar P., Wiebe L.I., et al. Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation. Appl Radiat Isot 2005, 62:897-901.
22. Ashioti M., Beech J.S., Lowe A.S., Hesselink M.B., Modo M., Williams S.C. Multi-modal characterisation of the neocortical clip model of focal cerebral ischaemia by MRI, behaviour and immunohistochemistry. Brain Res 2007, 1145:177-189.
23. Rogers J.G., Harrop R., Kinahan P.E. The theory of three-dimensional image reconstruction for PET. IEEE Trans Med Imaging 1987, 6:239-243.
24. Hughes J.L., Jones P.S., Beech J.S., Wang D., Menon D.K., Aigbirhio F.I., et al. A microPET study of the regional distribution of [(11)C]-PK11195 binding following temporary focal cerebral ischemia in the rat. Correlation with post mortem mapping of microglia activation. Neuroimage 2012, 59:2007-2016.
25. Duverger D., MacKenzie E.T. The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J Cereb Blood Flow Metab 1988, 8:449-461.
26. McCabe C., Gallagher L., Gsell W., Graham D., Dominiczak A.F., Macrae I.M. Differences in the evolution of the ischemic penumbra in stroke-prone spontaneously hypertensive and Wistar-Kyoto rats. Stroke 2009, 40:3864-3868.
27. Letourneur A., Roussel S., Toutain J., Bernaudin M., Touzani O. Impact of genetic and renovascular chronic arterial hypertension on the acute spatiotemporal evolution of the ischemic penumbra: a sequential study with MRI in the rat. J Cereb Blood Flow Metab 2011, 31:504-513.
28. Markus R., Reutens D.C., Kazui S., Read S., Wright P., Chambers B.R., et al. Topography and temporal evolution of hypoxic viable tissue identified by 18F-fluoromisonidazole positron emission tomography in humans after ischemic stroke. Stroke 2003, 34:2646-2652.
29. Spratt N.J., Donnan G.A., Howells D.W. Characterisation of the timing of binding of the hypoxia tracer FMISO after stroke. Brain Res 2009, 1288:135-142.
30. Elsinga P.H., Hendrikse N.H., Bart J., Vaalburg W., van Waarde A. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS. Curr Pharm Des 2004, 10:1493-1503.
31. Isozaki M., Kiyono Y., Arai Y., Kudo T., Mori T., Maruyama R., et al. Feasibility of 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease. Eur J Nucl Med Mol Imaging 2011, 38:1075-1082.